ACT SCIENCES - Key Persons
Co-Founder at Talus Bio. PhD in Chemical Biology, Harvard 2015. Formerly Lead Bioinformatics Scientist & Pharma Alliance Manager at SEngine Performance Medicine, Seattle, WA; applying how cancer drugs work with complex cellular networks, how we can best use the drugs, and better develop new ones.
Job Titles:
- RESEARCH LEAD / SCIENTIFIC ADVISOR
A renowned author of multiple books on addiction. Jack has been speaking around the country for over 20 years at conferences, treatment centers and to corporations, churches/ temples, colleges and numerous addiction communities through-out the US. He has extensive experience as a top-tier management executive in a variety of industries, including advertising, television production, large-scale solar generation, publishing, specialty food distribution, and healthcare.
Associate Professor of Pharmacology, Toxicology and Neuroscience, Associate Professor of Psychiatry, Director of Basic Science Research for Louisiana Addiction Research Center. Dr. Kevin contributes more than 10 years of drug development and medical business experience to the team, and his group is presently developing a new medical delivery device. Recent studies in his laboratory include the development of natural products that reduce neuro-inflammation, to develop disease-modifying.
Job Titles:
- BUSINESS ADVISOR
- Founding Director and Chairman of the N.O.W. Matters More Foundation
Lui Delgado is the founding director and chairman of the N.O.W. Matters More Foundation. Also known as "The Dope Doctor," he is a certified addiction professional (CAP) and co-host of the Couch Live Radio Show. He's a columnist and a treatment service consultant for many clients and patients.
Founder of Levine and Associates law firm of Scarsdale, NY. A graduate of Brooklyn Law, Michael has been practicing corporate law for over 43 years. Michael serves as in-house council for ACT SCIENCES.
Wayne Gill is a business lawyer, entrepreneur and leadership coach working with founders and entrepreneurs to launch and scale high-impact businesses. He advises ACT SCIENCES in the areas of governance, corporate strategy, and capitalization.